Related references
Note: Only part of the references are listed.Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Phase I Trial of Autologous CAR T Cells Targeting NKG2D Ligands in Patients with AML/MDS and Multiple Myeloma
Susanne H. Baumeister et al.
CANCER IMMUNOLOGY RESEARCH (2019)
NKG2D/NKG2-Ligand Pathway Offers New Opportunities in Cancer Treatment
Alexandra Frazao et al.
FRONTIERS IN IMMUNOLOGY (2019)
Metastatic prostate cancer remains incurable, why?
Liang Dong et al.
ASIAN JOURNAL OF UROLOGY (2019)
High CD8(+) and absence of Foxp3(+) T lymphocytes infiltration in gallbladder tumors correlate with prolonged patients survival
Paula Fluxa et al.
BMC CANCER (2018)
Control of triple-negative breast cancer using ex vivo self-enriched, costimulated NKG2D CAR T cells
Yali Han et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Development of NKG2D-based chimeric antigen receptor-T cells for gastric cancer treatment
Kelong Tao et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2018)
Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks
Michael C. Comiskey et al.
CURRENT ONCOLOGY REPORTS (2018)
Exploiting natural killer group 2D receptors for CAR T-cell therapy
Benjamin Demoulin et al.
FUTURE ONCOLOGY (2017)
Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells
Thomas Shum et al.
CANCER DISCOVERY (2017)
CARTs for Solid Tumors: Feasible or Infeasible?
Wei Li et al.
ONCOLOGY RESEARCH AND TREATMENT (2017)
Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment
Meike Vogler et al.
BRITISH JOURNAL OF HAEMATOLOGY (2017)
CD69: from activation marker to metabolic gatekeeper
Danay Cibrian et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2017)
Chimeric antigen receptor-modified T cells for the immunotherapy of patients with EGFR-expressing advanced relapsed/refractory non-small cell lung cancer
Kaichao Feng et al.
SCIENCE CHINA-LIFE SCIENCES (2016)
Different Subsets of T Cells, Memory, Effector Functions, and CAR-T Immunotherapy
Vita Golubovskaya et al.
CANCERS (2016)
Chimeric Antigen Receptor-Engineered T Cells for the Treatment of Metastatic Prostate Cancer
Victoria Hillerdal et al.
BIODRUGS (2015)
Human Epidermal Growth Factor Receptor 2 (HER2) -Specific Chimeric Antigen Receptor-Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
Nabil Ahmed et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
IL-12 secreting tumor-targeted chimeric antigen receptor T cells eradicate ovarian tumors in vivo
Mythili Koneru et al.
ONCOIMMUNOLOGY (2015)
Type 1 interferon-induced IL-7 maintains CD8+ T-cell responses and homeostasis by suppressing PD-1 expression in viral hepatitis
Lifei Hou et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2015)
Perforin and granzymes: function, dysfunction and human pathology
Ilia Voskoboinik et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Closely related T-memory stem cells correlate with in vivo expansion of CAR.CD19-T cells and are preserved by IL-7 and IL-15
Yang Xu et al.
BLOOD (2014)
CAR T Cells for Solid Tumors Armed and Ready to Go?
Sunitha Kakarla et al.
CANCER JOURNAL (2014)
NKG2D CARs as Cell Therapy for Cancer
Charles L. Sentman et al.
CANCER JOURNAL (2014)
PSMA-Specific CAR-Engineered T Cells Eradicate Disseminated Prostate Cancer in Preclinical Models
Gaia Zuccolotto et al.
PLOS ONE (2014)
Regulation of Ligands for the NKG2D Activating Receptor
David H. Raulet et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Chimeric NKG2D CAR-Expressing T Cell-Mediated Attack of Human Ovarian Cancer Is Enhanced by Histone Deacetylase Inhibition
De-Gang Song et al.
HUMAN GENE THERAPY (2013)
Is CD69 an effective brake to control inflammatory diseases?
Roberto Gonzalez-Amaro et al.
TRENDS IN MOLECULAR MEDICINE (2013)
CD20-specific adoptive immunotherapy for lymphoma using a chimeric antigen receptor with both CD28 and 4-1BB domains: pilot clinical trial results
Brian G. Till et al.
BLOOD (2012)
IL-7 Abrogates Suppressive Activity of Human CD4+CD25+ FOXP3+ Regulatory T Cells and Allows Expansion of Alloreactive and Autoreactive T Cells
Anne-Kristin Heninger et al.
JOURNAL OF IMMUNOLOGY (2012)
In vitro generated anti-tumor T lymphocytes exhibit distinct subsets mimicking in vivo antigen-experienced cells
Shicheng Yang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
Marc Pellegrini et al.
CELL (2011)
A human memory T cell subset with stem cell-like properties
Luca Gattinoni et al.
NATURE MEDICINE (2011)
Harnessing the biology of IL-7 for therapeutic application
Crystal L. Mackall et al.
NATURE REVIEWS IMMUNOLOGY (2011)
IL-7 and IL-21 are superior to IL-2 and IL-15 in promoting human T cell-mediated rejection of systemic lymphoma in immunodeficient mice
John C. Markley et al.
BLOOD (2010)
Ex vivo culture of chimeric antigen receptor T cells generates functional CD8+ T cells with effector and central memory-like phenotype
P. Neeson et al.
GENE THERAPY (2010)
Engineering CD19-specific T lymphocytes with interleukin-15 and a suicide gene to enhance their anti-lymphoma/leukemia effects and safety
V. Hoyos et al.
LEUKEMIA (2010)
IL-7 Promotes CXCR3 Ligand-Dependent T Cell Antitumor Reactivity in Lung Cancer
Asa Andersson et al.
JOURNAL OF IMMUNOLOGY (2009)
Simplified lentivirus vector production in protein-free media using polyethylenimine-mediated transfection
Hitoshi Kuroda et al.
JOURNAL OF VIROLOGICAL METHODS (2009)
Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo
Michael C. Milone et al.
MOLECULAR THERAPY (2009)
Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies
Marc Pellegrini et al.
NATURE MEDICINE (2009)
New insights into the regulation of T cells by γc family cytokines
Yrina Rochman et al.
NATURE REVIEWS IMMUNOLOGY (2009)
IL-7 promotes Glut1 trafficking and glucose uptake via STAT5-mediated activation of Akt to support T-cell survival
Jessica A. Wofford et al.
BLOOD (2008)
Adoptive cell transfer: a clinical path to effective cancer immunotherapy
Steven A. Rosenberg et al.
NATURE REVIEWS CANCER (2008)
Granzyme B is critical for T cell receptor-induced cell death of type 2 helper T cells
Satish Devadas et al.
IMMUNITY (2006)
Cell biology of IL-7, a key lymphotrophin
Q Jiang et al.
CYTOKINE & GROWTH FACTOR REVIEWS (2005)
Chimeric receptors with 4-1BB signaling capacity provoke potent cytotoxicity against acute lymphoblastic leukemia
C Imai et al.
LEUKEMIA (2004)
Adoptive-cell-transfer therapy for the treatment of patients with cancer
ME Dudley et al.
NATURE REVIEWS CANCER (2003)
Functional expression and release of ligands for the activating immunoreceptor NKG2D in leukemia
HR Salih et al.
BLOOD (2003)
4-1 BB enhances CD8+ T cell expansion by regulating cell cycle progression through changes in expression of cyclins D and E and cyclin-dependent kinase inhibitor p27kip1
HW Lee et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Share Paper
